Otc - Active Ingredient
Bufo rana
6C,9C,12C,30C,200CK
Bufo Rana Pellet
FDA Label NDC 0220-0925
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Boiron for the product Bufo Rana (NDC 0220-0925). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, indications & usage, otc - stop use, otc - pregnancy or breast feeding, otc - keep out of reach of children, dosage & administration, inactive ingredient, otc - questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Indications & Usage
Rx Only*
Otc - Stop Use
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen
Otc - Pregnancy Or Breast Feeding
If pregnant or breast-feeding ask a health professional before use
Otc - Keep Out Of Reach Of Children
Keep out of reach of children
Dosage & Administration
5 pellets 3 times a day until symptoms are relieved
Inactive Ingredient
lactose, sucrose
Otc - Questions
1-800-BOIRON-1, Newtown Square, PA 19073-3267, [email protected]
Other
These "Uses" have not been evaluated by the FDA
* Please review the disclaimer below.
